Last update 01 Nov 2024
Nutrinia Ltd.

Nutrinia Ltd.

Private Company|
2003|
Israel
|
10-50
|
www.nutrinia.com

Overview

Tags

Digestive System Disorders
Hormone

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Hormone1
Top 5 TargetCount
INSR(Insulin receptor)1

Related

2
Drugs associated with Nutrinia Ltd.
NTRA-2112
Target
INSR
Mechanism
INSR agonists
Active Org.
Nutrinia Ltd.Nutrinia Ltd.
Originator Org.
Nutrinia Ltd.Nutrinia Ltd.
Active Indication
Gastrointestinal Diseases
Inactive Indication
Malabsorption Syndromes [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Recombinant human insulin(Nutrinia Ltd.)
Target
INSR
Mechanism
INSR agonists
Active Org.-
Originator Org.
Nutrinia Ltd.Nutrinia Ltd.
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2 [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Nutrinia Ltd.
NCT02510560 / Unknown statusPhase 3
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
100 Clinical Results associated with Nutrinia Ltd.
Login to view more data
0 Patents (Medical) associated with Nutrinia Ltd.
Login to view more data
100 Deals associated with Nutrinia Ltd.
Login to view more data
100 Translational Medicine associated with Nutrinia Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NTRA-2112
 ( INSR )		Gastrointestinal Diseases
More
Phase 3
Recombinant human insulin(Nutrinia Ltd.)
 ( INSR )		Short Bowel Syndrome
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free